Jonsson Comprehensive Cancer Center

🇺🇸United States

Country: 🇺🇸United States

Ownership: Subsidiary

Employees: -

Market Cap: -

Website: http://www.cancer.ucla.edu

Clinical Trials

Oblimersen and Dacarbazine in Treating Patients With Advanced Malignant Melanoma That Has Responded to Treatment on Clinical Trial GENTA-GM301

Not Applicable

Conditions: Melanoma (Skin)

First Posted Date: 2003-10-07

Last Posted Date: 2014-01-06

Lead Sponsor: Jonsson Comprehensive Cancer Center

Registration Number: NCT00070343

Locations: 🇺🇸
Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California, United States

Vaccine Therapy in Treating Patients With Liver Cancer

Phase 1

Completed

Conditions: Liver Cancer

Interventions: Biological: AFP gene hepatocellular carcinoma vaccine

First Posted Date: 2003-10-01

Last Posted Date: 2020-08-03

Lead Sponsor: Jonsson Comprehensive Cancer Center

Target Recruit Count: 6

Registration Number: NCT00005629

Locations: 🇺🇸
Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California, United States

Docetaxel and Carboplatin With or Without Trastuzumab Before Surgery in Treating Women With Locally Advanced Breast Cancer

Phase 2

Completed

Conditions: Breast Cancer

Interventions: Biological: trastuzumab
Drug: carboplatin
Drug: docetaxel

First Posted Date: 2003-09-11

Last Posted Date: 2020-09-09

Lead Sponsor: Jonsson Comprehensive Cancer Center

Target Recruit Count: 74

Registration Number: NCT00068341

Locations: 🇺🇸
USC/Norris Comprehensive Cancer Center and Hospital, Los Angeles, California, United States
🇺🇸
Jonsson Comprehensive Cancer Center at UCLA, Los Angeles, California, United States
🇺🇸
Wilshire Oncology Medical Group, Incorporated - Pomona, Pomona, California, United States

and more 1 locations

Vaccine Therapy in Treating Patients With Malignant Glioma

Phase 1

Completed

Conditions: Brain and Central Nervous System Tumors

Interventions: Biological: therapeutic autologous dendritic cells

First Posted Date: 2003-09-11

Last Posted Date: 2020-08-03

Lead Sponsor: Jonsson Comprehensive Cancer Center

Target Recruit Count: 28

Registration Number: NCT00068510

Locations: 🇺🇸
Jonsson Comprehensive Cancer Center at UCLA, Los Angeles, California, United States

Tocladesine in Treating Patients With Recurrent or Progressive Metastatic Colorectal Cancer

Phase 1

Conditions: Colorectal Cancer

First Posted Date: 2003-09-10

Last Posted Date: 2013-08-02

Lead Sponsor: Jonsson Comprehensive Cancer Center

Registration Number: NCT00021268

Locations: 🇺🇸
Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California, United States

Monoclonal Antibody Therapy in Treating Women With Locally Advanced or Metastatic Breast Cancer Previously Treated With Combination Chemotherapy

Phase 1

Conditions: Breast Cancer

First Posted Date: 2003-08-07

Last Posted Date: 2013-12-04

Lead Sponsor: Jonsson Comprehensive Cancer Center

Registration Number: NCT00066547

Locations: 🇺🇸
Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California, United States

Bortezomib in Treating Patients With Diffuse Large B-Cell Lymphoma That Is Refractory To Chemotherapy

Phase 2

Completed

Conditions: Lymphoma

First Posted Date: 2003-08-07

Last Posted Date: 2013-01-08

Lead Sponsor: Jonsson Comprehensive Cancer Center

Target Recruit Count: 7

Registration Number: NCT00066508

Locations: 🇺🇸
Jonsson Comprehensive Cancer Center at UCLA, Los Angeles, California, United States

BMS-354825 in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia That Is Resistant to Imatinib Mesylate

Phase 1

Completed

Conditions: Leukemia

First Posted Date: 2003-07-09

Last Posted Date: 2020-08-03

Lead Sponsor: Jonsson Comprehensive Cancer Center

Target Recruit Count: 42

Registration Number: NCT00064233

Locations: 🇺🇸
Jonsson Comprehensive Cancer Center at UCLA, Los Angeles, California, United States

Pentostatin Followed by Peripheral Stem Cell Transplantation in Treating Patients With Advanced Kidney Cancer

Phase 1

Completed

Conditions: Kidney Cancer

First Posted Date: 2003-06-27

Last Posted Date: 2013-01-08

Lead Sponsor: Jonsson Comprehensive Cancer Center

Target Recruit Count: 4

Registration Number: NCT00006968

Locations: 🇺🇸
Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California, United States

Paclitaxel, Folic Acid, and Lometrexol in Treating Patients With Locally Advanced or Metastatic Solid Tumors

Phase 1

Conditions: Drug/Agent Toxicity by Tissue/Organ
Unspecified Adult Solid Tumor, Protocol Specific

First Posted Date: 2003-06-20

Last Posted Date: 2013-09-17

Lead Sponsor: Jonsson Comprehensive Cancer Center

Registration Number: NCT00024310

Locations: 🇺🇸
Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy